ABOUT ENDOJUMP™ ET TABLETS
ENDOJUMP™ ET combines Ethinyl Estradiol 30 mcg and Dienogest 2 mg in an oral hormonal formulation. This combined oral contraceptive primarily prevents pregnancy by suppressing ovulation and also produces changes in cervical mucus and the endometrium. Each blister contains 21 tablets intended for consistent use according to the prescribed dosing schedule.
Quality Focused
Developed with a focus on quality.
Convenient Tablet Form
Easy to administer
Part of a Wider Range
From Curo360 Lifesciences
Healthcare Commitment
Dedicated to quality healthcare solutions.
COMPOSITION DETAILS
What's Inside?
| Ingredient | Packing |
|---|---|
| Ethinyl Estradiol (30mcg) + Dienogest (2mg) | 10 × 1 × 21 Blister |
PRODUCT INFORMATION
Dosage Form
Tablet
Pack Size
10 × 1 × 21 Blister
Category
Hormonal Therapy
Brand
Curo360 Lifesciences
Why Curo360 Lifesciences?
As a focused gynae pharma company, Curo360 brings together a carefully developed portfolio covering key areas of gynaecological care.
Gynaecology
at the Core
A clear focus across
women’s health segments.
Purposeful Product
Portfolio
Formulations around specific healthcare needs.
Coverage That
Goes Deeper
Key therapeutic areas
under one portfolio.
Evolving with
Healthcare Needs
A range that grows with changing requirements.
FREQUENTLY ASKED QUESTIONS
What does ENDOJUMP™ ET contain? +
It contains Ethinyl Estradiol 30 mcg and Dienogest 2 mg.
What type of medicine is ENDOJUMP™ ET? +
It is a combined oral contraceptive containing an oestrogen and a progestogen.
How does ENDOJUMP™ ET help prevent pregnancy? +
It primarily suppresses ovulation and also produces changes in cervical mucus and the endometrium.
How many tablets are included in each blister? +
Each blister contains 21 tablets.
Is consistent use important with ENDOJUMP™ ET? +
Yes, consistent use according to the recommended schedule is important for contraceptive effectiveness.










